Prognostic value of high serum lactate dehydrogenase in plasma cell dyscrasias: a re-evaluation in the context of cytogenetic aberration data

被引：1

作者：

An, Gang ^{[1
,2
,3
]}

Shi, Lihui ^{[1
,2
,3
]}

Xu, Yan ^{[1
,2
,3
]}

Zou, Dehui ^{[1
,2
,3
]}

Deng, Shuhui ^{[1
,2
,3
]}

Sui, Weiwei ^{[1
,2
,3
]}

Zhu, Guoqing ^{[1
,2
,3
]}

Xie, Zhenqing ^{[1
,2
,3
]}

Hao, Mu ^{[1
,2
,3
]}

Sun, Qi ^{[1
,2
,3
]}

Zhan, Fenghuang ^{[4
]}

Qiu, Lugui ^{[1
,2
,3
,5
]}

机构：

[1] Chinese Acad Med Sci, Inst Hematol, Dept Lymphoma & Myeloma, Tianjin, Peoples R China

[2] Chinese Acad Med Sci, Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China

[3] Peking Union Med Coll, Tianjin, Peoples R China

[4] Univ Iowa, Dept Internal Med, Div Hematol Oncol & Blood & Marrow Transplantat, Iowa City, IA 52242 USA

[5] Umbil Cord Blood Bank Tianjin, Tianjin, Peoples R China

来源：

LEUKEMIA & LYMPHOMA | 2013年 / 54卷 / 11期

关键词：

MYELOMA WORKING GROUP; MULTIPLE-MYELOMA; STAGING SYSTEM; CLASSIFICATION; THALIDOMIDE; DISORDERS; TRIAL;

D O I：

10.3109/10428194.2013.776168

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2556 / 2559

页数：4

共 11 条

[1]

[Anonymous], BR J HAEMATOL

[2] Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome [J].

Avet-Loiseau, Herve ;

Attal, Michel ;

Moreau, Philippe ;

Charbonnel, Catherine ;

Garban, Frederic ;

Hulin, Cyrille ;

Leyvraz, Serge ;

Michallet, Mauricette ;

Yakoub-Agha, Ibrahim ;

Garderet, Laurent ;

Marit, Gerald ;

Michaux, Lucienne ;

Voillat, Laurent ;

Renaud, Marc ;

Grosbois, Bernard ;

Guillerm, Gaelle ;

Benboubker, Lotfi ;

Monconduit, Mathieu ;

Thieblemont, Catherine ;

Casassus, Philippe ;

Caillot, Denis ;

Stoppa, Anne-Marie ;

Sotto, Jean-Jacques ;

Wetterwald, Marc ;

Dumontet, Charles ;

Fuzibet, Jean-Gabriel ;

Azais, Isabelle ;

Dorvaux, Veronique ;

Zandecki, Marc ;

Bataille, Regis ;

Minvielle, Stephane ;

Harousseau, Jean-Luc ;

Facon, Thierry ;

Mathiot, Claire .

BLOOD, 2007, 109 (08) :3489-3495

[3] HIGH SERUM LEVELS OF LACTIC-DEHYDROGENASE IDENTIFY A HIGH-GRADE LYMPHOMA-LIKE MYELOMA [J].

BARLOGIE, B ;

SMALLWOOD, L ;

SMITH, T ;

ALEXANIAN, R .

ANNALS OF INTERNAL MEDICINE, 1989, 110 (07) :521-525

[4] Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3 [J].

Barlogie, Bart ;

Anaissie, Elias ;

van Rhee, Frits ;

Haessler, Jeffrey ;

Hollmig, Klaus ;

Pineda-Roman, Mauricio ;

Cottler-Fox, Michele ;

Mohiuddin, Abid ;

Alsayed, Yazan ;

Tricot, Guido ;

Bolejack, Vanessa ;

Zangari, Maurizio ;

Epstein, Joshua ;

Petty, Nathan ;

Steward, Douglas ;

Jenkins, Bonnie ;

Gurley, Jennifer ;

Sullivan, Ellen ;

Crowley, John ;

Shaughnessy, John D. Jr .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (02) :176-185

[5] International Myeloma Working Group molecular classification of multiple myeloma: spotlight review [J].

Fonseca, R. ;

Bergsagel, P. L. ;

Drach, J. ;

Shaughnessy, J. ;

Gutierrez, N. ;

Stewart, A. K. ;

Morgan, G. ;

Van Ness, B. ;

Chesi, M. ;

Minvielle, S. ;

Neri, A. ;

Barlogie, B. ;

Kuehl, W. M. ;

Liebisch, P. ;

Davies, F. ;

Chen-Kiang, S. ;

Durie, B. G. M. ;

Carrasco, R. ;

Sezer, Orhan ;

Reiman, Tony ;

Pilarski, Linda ;

Avet-Loiseau, H. .

LEUKEMIA, 2009, 23 (12) :2210-2221

[6] Increased Serum Lactate Dehydrongenase Should Be Included Among the Variables That Define Very-High-Risk Multiple Myeloma [J].

Gkotzamanidou, Maria ;

Kastritis, Efstathios ;

Gavriatopoulou, Maria Roussou Magdalini Migkou Maria ;

Nikitas, Nikitas ;

Gika, Dimitra ;

Mparmparousi, Despina ;

Matsouka, Charis ;

Terpos, Evangelos ;

Dimopoulos, Meletios A. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (05) :409-413

[7] International staging system for multiple myeloma [J].

Greipp, PR ;

San Miguel, J ;

Durie, BGM ;

Crowley, JJ ;

Barlogie, B ;

Bladé, J ;

Boccadoro, M ;

Child, JA ;

Harousseau, JL ;

Kyle, RA ;

Lahuerta, JJ ;

Ludwig, H ;

Morgan, G ;

Powles, R ;

Shimizu, K ;

Shustik, C ;

Sonneveld, P ;

Tosi, P ;

Turesson, I ;

Westin, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3412-3420

[8] Phase II Study of Thalidomide Plus Dexamethasone Induction Followed by Tandem Melphalan-Based Autotransplantation and Thalidomide-Plus-Prednisone Maintenance for Untreated Multiple Myeloma: A Southwest Oncology Group Trial (S0204) [J].

Hussein, Mohamad A. ;

Bolejack, Vanessa ;

Zonder, Jeffrey A. ;

Durie, Brian G. M. ;

Jakubowiak, Andrzej J. ;

Crowley, John J. ;

Barlogie, Bart .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) :3510-3517

[9] Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age [J].

Mileshkin, L ;

Biagi, JJ ;

Mitchell, P ;

Underhill, C ;

Grigg, A ;

Bell, R ;

McKendrick, J ;

Briggs, P ;

Seymour, JF ;

Lillie, K ;

Smith, JG ;

Zeldis, JB ;

Prince, HM .

BLOOD, 2003, 102 (01) :69-77

[10] Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders [J].

Ross, Fiona M. ;

Avet-Loiseau, Herve ;

Ameye, Genevieve ;

Gutierrez, Norma C. ;

Liebisch, Peter ;

O'Connor, Sheila ;

Dalva, Klara ;

Fabris, Sonia ;

Testi, Adele M. ;

Jarosova, Marie ;

Hodkinson, Clare ;

Collin, Anna ;

Kerndrup, Gitte ;

Kuglik, Petr ;

Ladon, Dariusz ;

Bernasconi, Paolo ;

Maes, Brigitte ;

Zemanova, Zuzana ;

Michalova, Kyra ;

Michau, Lucienne ;

Neben, Kai ;

Hermansen, N. Emil U. ;

Rack, Katrina ;

Rocci, Alberto ;

Protheroe, Rebecca ;

Chiecchio, Laura ;

Poirel, Helene A. ;

Sonneveld, Pieter ;

Nyegaard, Mette ;

Johnsen, Hans E. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08) :1272-1277

← 1 2 →